Northern Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.46M | Sell |
990,646
-136,012
| -12% | -$709K | ﹤0.01% | 2518 |
|
|
2025
Q4 | $6.93M | Sell |
1,126,658
-8,907
| -0.8% | -$64.6K | ﹤0.01% | 2285 |
|
|
2025
Q3 | $8.21M | Buy |
1,135,565
+176,794
| +18% | +$1.05M | ﹤0.01% | 2228 |
|
|
2025
Q2 | $5.09M | Sell |
958,771
-54,785
| -5% | -$324K | ﹤0.01% | 2450 |
|
|
2025
Q1 | $8.99M | Sell |
1,013,556
-18,576
| -2% | -$223K | ﹤0.01% | 2101 |
|
|
2024
Q4 | $14.2M | Buy |
1,032,132
+64,923
| +7% | +$1.2M | ﹤0.01% | 1920 |
|
|
2024
Q3 | $26.5M | Buy |
967,209
+33,288
| +4% | +$901K | ﹤0.01% | 1449 |
|
|
2024
Q2 | $22.8M | Sell |
933,921
-22,435
| -2% | -$492K | ﹤0.01% | 1470 |
|
|
2024
Q1 | $20.4M | Buy |
956,356
+14,219
| +2% | +$306K | ﹤0.01% | 1583 |
|
|
2023
Q4 | $18M | Sell |
942,137
-80,002
| -8% | -$1.38M | ﹤0.01% | 1686 |
|
|
2023
Q3 | $16.4M | Buy |
1,022,139
+2,238
| +0.2% | +$42.6K | ﹤0.01% | 1685 |
|
|
2023
Q2 | $23.6M | Buy |
1,019,901
+22,706
| +2% | +$496K | ﹤0.01% | 1474 |
|
|
2023
Q1 | $23.2M | Sell |
997,195
-12,161
| -1% | -$247K | ﹤0.01% | 1460 |
|
|
2022
Q4 | $14.6M | Sell |
1,009,356
-194,425
| -16% | -$3.62M | ﹤0.01% | 1748 |
|
|
2022
Q3 | $23M | Sell |
1,203,781
-32,464
| -3% | -$745K | 0.01% | 1372 |
|
|
2022
Q2 | $22.5M | Sell |
1,236,245
-7,418
| -0.6% | -$154K | ﹤0.01% | 1447 |
|
|
2022
Q1 | $31.3M | Sell |
1,243,663
-41,159
| -3% | -$1.05M | 0.01% | 1362 |
|
|
2021
Q4 | $35.5M | Sell |
1,284,822
-1,021
| -0.1% | -$29.6K | 0.01% | 1362 |
|
|
2021
Q3 | $41.5M | Sell |
1,285,843
-32,582
| -2% | -$1.08M | 0.01% | 1233 |
|
|
2021
Q2 | $40.3M | Buy |
1,318,425
+54,934
| +4% | +$1.59M | 0.01% | 1319 |
|
|
2021
Q1 | $38.5M | Sell |
1,263,491
-448,625
| -26% | -$12.7M | 0.01% | 1334 |
|
|
2020
Q4 | $33.9M | Sell |
1,712,116
-148,739
| -8% | -$2.4M | 0.01% | 1390 |
|
|
2020
Q3 | $24.3M | Sell |
1,860,855
-62,529
| -3% | -$791K | 0.01% | 1478 |
|
|
2020
Q2 | $21.8M | Buy |
1,923,384
+33,348
| +2% | +$474K | 0.01% | 1548 |
|
|
2020
Q1 | $27M | Buy |
1,890,036
+8,904
| +0.5% | +$188K | 0.01% | 1188 |
|
|
2019
Q4 | $51.2M | Sell |
1,881,132
-15,683
| -0.8% | -$431K | 0.01% | 1002 |
|
|
2019
Q3 | $54.3M | Buy |
1,896,815
+101,347
| +6% | +$2.95M | 0.01% | 903 |
|
|
2019
Q2 | $49.9M | Buy |
1,795,468
+103,590
| +6% | +$2.93M | 0.01% | 999 |
|
|
2019
Q1 | $56.2M | Sell |
1,691,878
-201
| -0% | -$6.12K | 0.01% | 876 |
|
|
2018
Q4 | $49.2M | Buy |
1,692,079
+34,066
| +2% | +$1.23M | 0.01% | 866 |
|
|
2018
Q3 | $76.3M | Sell |
1,658,013
-143,869
| -8% | -$6.4M | 0.02% | 704 |
|
|
2018
Q2 | $67.3M | Buy |
1,801,882
+47,994
| +3% | +$1.62M | 0.02% | 770 |
|
|
2018
Q1 | $51.8M | Buy |
1,753,888
+102,920
| +6% | +$3.48M | 0.01% | 967 |
|
|
2017
Q4 | $56.7M | Buy |
1,650,968
+117,934
| +8% | +$3.98M | 0.01% | 892 |
|
|
2017
Q3 | $55.5M | Buy |
1,533,034
+240,446
| +19% | +$6.86M | 0.01% | 877 |
|
|
2017
Q2 | $33.4M | Buy |
1,292,588
+306,276
| +31% | +$6.5M | 0.01% | 1273 |
|
|
2017
Q1 | $18.9M | Buy |
986,312
+149
| +0% | +$2.64K | 0.01% | 1666 |
|
|
2016
Q4 | $16.4M | Sell |
986,163
-32,978
| -3% | -$597K | 0.01% | 1741 |
|
|
2016
Q3 | $21M | Sell |
1,019,141
-6,363
| -0.6% | -$161K | 0.01% | 1557 |
|
|
2016
Q2 | $31.4M | Sell |
1,025,504
-13,529
| -1% | -$470K | 0.01% | 1135 |
|
|
2016
Q1 | $38.9M | Buy |
1,039,033
+12,969
| +1% | +$489K | 0.01% | 975 |
|
|
2015
Q4 | $44.3M | Buy |
1,026,064
+25,891
| +3% | +$1.09M | 0.01% | 895 |
|
|
2015
Q3 | $37.5M | Buy |
1,000,173
+409,092
| +69% | +$14.5M | 0.01% | 991 |
|
|
2015
Q2 | $20.1M | Buy |
591,081
+162,618
| +38% | +$5.53M | 0.01% | 1578 |
|
|
2015
Q1 | $15.2M | Buy |
428,463
+6,151
| +1% | +$220K | ﹤0.01% | 1787 |
|
|
2014
Q4 | $14.4M | Sell |
422,312
-8,374
| -2% | -$297K | ﹤0.01% | 1787 |
|
|
2014
Q3 | $16.6M | Buy |
430,686
+36,833
| +9% | +$1.37M | 0.01% | 1647 |
|
|
2014
Q2 | $15.3M | Sell |
393,853
-69,951
| -15% | -$2.6M | ﹤0.01% | 1737 |
|
|
2014
Q1 | $15.9M | Buy |
463,804
+52,573
| +13% | +$1.63M | 0.01% | 1768 |
|
|
2013
Q4 | $8.63M | Buy |
411,231
+39,359
| +11% | +$995K | ﹤0.01% | 2183 |
|
|
2013
Q3 | $8.74M | Buy |
371,872
+13,295
| +4% | +$378K | ﹤0.01% | 2109 |
|
|
2013
Q2 | $9.64M | Buy |
+358,577
| New | +$10.4M | ﹤0.01% | 1949 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
Northern Trust's MYGN Position: Q1 2026 in Review
Northern Trust reduced its Myriad Genetics (MYGN) stake by 12% in Q1 2026, selling an estimated $709K and leaving 990,646 shares worth $4.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2518.
Northern Trust first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $76.3M in Q3 2018. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Northern Trust held 990,646 shares of Myriad Genetics worth $4.46M as of Q1 2026.
- Northern Trust sold 136,012 Myriad Genetics shares in Q1 2026, an estimated $709K.
- Myriad Genetics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2518 holding.
- Northern Trust first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Myriad Genetics position peaked at $76.3M in Q3 2018.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.